Endoscope Reprocessing Market - Growth, Trends, Covid-19 Impact, Forecasts (2021 - 2026)

The Endoscope Reprocessing Market is segmented by Product (High-level Disinfectants and Test Strips, Detergents and Wipes, Automated Endoscope Reprocessors, Endoscope Drying, Storage and Transport Systems, and Other Products), End User (Hospitals, Ambulatory Surgery Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Endoscope Reprocessing Market Bar Graph
Study Period: 2018-2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.8 %
Endoscope Reprocessing Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The endoscope reprocessing market was valued at approximately USD 1,716.5 million in 2020 and is expected to reach USD 2690.5 million by 2026, by registering a CAGR of about 7.8% over the forecast period, 2021-2026.

There is a high risk of transmission of the COVID-19 virus during endoscopy surgery. Various countries have penned down several guidelines to keep all non-emergent surgeries on halt. In September 2020, the Department of Medicine A, University Medicine Greifswald, Germany, conducted a survey in 48 countries and discovered that during the COVID-19 pandemic, all centers (99%) reduced their endoscopy volumes. A majority of these centers (85%) reported greater than 50% reduction in endoscopy volumes. This data suggests that due to a halt in endoscopy surgeries, the market is expected to experience a slight negative growth. However, with the current attempts at controlling the pandemic and the arrival of the vaccine in the market space, the growth is expected to resume.

The major factors driving the growth of the endoscope reprocessing market include the rising cases of endoscopy-related infections, growing hospital investments in endoscopy instruments, and the rising number of diseases that require endoscopy procedures. Increased usage of endoscopic devices has been observed in disease diagnosis and treatment. The growing burden of diseases that can be detected by endoscopy has increased the demand for these devices.

As per the American Cancer Society’s estimates, the number of new colorectal cancer cases in the United States by the end of 2018 reached 97,220, while the number of new cases of rectal cancer reached 43,030. This high incidence indicates the demand for screening by colonoscopic devices or sigmoidoscopic devices, which further drives the growth of the market.

Also, as per OECD, the total number of coronary heart bypass graft procedures performed, majorly accompanied by the use of endoscope, in 2018, was 45,307 in Germany, 20,324 in Canada, 19,006 in France, 20,411 in Italy, and 15,818 in the United Kingdom. The increasing geriatric population and the high prevalence of chronic diseases worldwide have led to the increasing number of surgeries being performed globally every year.

The growth of the market is also attributed to the rising adoption of endoscope reprocessing systems in hospitals for infection control and prevention and an increasing number of endoscopy procedures, coupled with growing concerns about patient safety among clinicians, development of novel automated endoscope reprocessors, and rising aging population.

Furthermore, rising demand for surgeries with faster recovery, fewer post-surgery infections, less pain, reduced scarring, better control on bleeding, and increased accuracy are anticipated to boost the demand for various endoscopy devices. Major players in the market are focusing on the approval of new products to expand their product portfolio. For instance, in April 2019, Advanced Sterilization Products received United States Food and Drug Administration’s approval for the ASP AEROFLEX Automatic Endoscope Reprocessor. Thus, the rising number of endoscopy reprocessing devices in the market will likely lead to the high growth of the market.

However, dearth of skilled professionals to carry out endoscopic procedures and the concerns regarding the safety of reprocessed instruments are the factors expected to hinder market growth.

Scope of the Report

As per the scope of this report, endoscope reprocessing is the validated process of cleaning, disinfecting, or sterilizing endoscopes and accessories. The endoscope reprocessing market is segmented by product (high-level disinfectants and test strips, detergents and wipes, automated endoscope reprocessors, endoscope drying, storage and transport systems, and other products), end user (hospitals, ambulatory surgery centers, and others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
High-Level Disinfectants and Test Strips
Detergents and Wipes
Automated Endoscope Reprocessors
Endoscope Drying, Storage, and Transport Systems
Other Products
By End User
Hospitals
Ambulatory Surgery Centers
Other End Users
Geography
North America
United States (By Product and By End User)
Canada (By Product and By End User)
Mexico (By Product and By End User)
Europe
Germany (By Product and By End User)
United Kingdom (By Product and By End User)
France (By Product and By End User)
Italy (By Product and By End User)
Spain (By Product and By End User)
Rest of Europe (By Product and By End User)
Asia-Pacific
China (By Product and By End User)
Japan (By Product and By End User)
India (By Product and By End User)
Australia (By Product and By End User)
South Korea (By Product and By End User)
Rest of Asia-Pacific (By Product and By End User)
Middle East and Africa
GCC (By Product and By End User)
South Africa (By Product and By End User)
Rest of Middle East and Africa (By Product and By End User)
South America
Brazil (By Product and By End User)
Argentina (By Product and By End User)
Rest of South America (By Product and By End User)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Automated Endoscope Reprocessors Segment is Expected to Register Good Growth Over the Forecast Period

During the current COVID-19 pandemic, when sterilization has become of utmost priority, the importance of automated endoscope reprocessors has grown as these reprocessors have become an essential part of the preparations for endoscopic surgeries. Hence, they have seen increased adoption in hospitals and clinics. The automated endoscope reprocessors are Class II devices and there is a huge demand for them owing to the benefits associated.

Furthermore, the United States Food and Drug Administration (US FDA) is steadily approving upcoming automated endoscope reprocessors. For instance, recently, in April 2018, Cantel Medical announced it has received 510 (k) clearance for its novel automated endoscope preprocessor. Thus, owing to the above-mentioned factors, the market is expected to witness sighnificant growth over the forecast period.

The graph given below suggests the estimated number of cancer cases in the United States. Growing cancer incidence in the United States is expected to boost the demand for various endoscopic procedures for the detection and diagnosis of tumor, which will ultimately lead to higher adoption of endoscope reprocessing devices to sterilize these endoscopes.

Endoscope Reprocessing Market Latest Trends

North America is Expected to Hold Largest Market Share over the Forecast Period

Community-based ambulatory endoscopy centers across the North American region are trying to reopen and safely resume outpatient endoscopic procedures, and the guidelines recommend reprocessing, pre-testing, and screening for COVID-19, along with other mitigation measures, for the safety of patients and staff. The impact of such changes on the workflow of endoscopy reprocessing is largely unknown, although a significant reduction in revenue stream is expected.

North America holds the majority of the share and in the North American region, the United States holds the major share. The United States is expected to be the largest endoscopy reprocessing market owing to the rising prevalence of diseases that require endoscopy procedures and the presence of better healthcare infrastructure.

According to a survey conducted in the United States, by the National Centre for Health Statistics, approximately 3.5 million Laparoscopic procedures were performed in the United States in the year 2017. The rising endoscopy procedures are expected to increase the demand for reprocessing products.

Furthermore, in the United States, there is a huge demand for minimally invasive surgeries which is leading to the increase in player base in the region along with various development by them due to leverage market opportunities.

For instance, in October 2019, Cantel Medical Corporation completed the acquisition of the Hu-Friedy Mfg. , the acquisition include the products such as highly processed medical device reprocessing system. Also, according to Globocan, in 2018, the incidence of stomach cancer in Canada was 3,244, pancreatic cancer was 5,139, and esophageal cancer was 2,619. This high rate of incidence of cancer also increased the requirement of endoscopic reprocessing devices, thereby leading to market growth. Hence, all the above mentioned factors is expected to augment the growth of the North American market over the forecast period.

Endoscope Reprocessing Market Growth Rate By Region

Competitive Landscape

The market studied involves both multinational and local companies owing to a large number of devices and consumables being used in the reprocessing process. Some of the market players are Advanced Sterilization Products (Johnson & Johnson Company), Cantel Medical, Custom Ultrasonics, Ecolab Inc, Endo-Technik W. Griesat, Getinge AB, Metrex Research, LLC., Olympus Corporation, STERIS plc., and Wassenburg Medical (A Member of Hoya).

Recent Developments

In October 2020, Olympus Corporation launched its OER-Elite next-generation automated endoscope reprocessor (AER) in the market.

In January 2020, PENTAX Medical launched DEC HD Duodenoscope, an advanced, high-definition duodenoscope that features multiple disposable components, including the sterile distal cap and elevator lever, for unit reprocessing in the United States.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Burden of Chronic Disorders and Cancer

      2. 4.2.2 Growing Preference for Minimally Invasive Surgeries

      3. 4.2.3 Growing Hospital Investments in Endoscopy Instruments, Coupled With Rising Adoption of Automated Reprocessed Endoscope

    3. 4.3 Market Restraints

      1. 4.3.1 Dearth of Skilled Professional

      2. 4.3.2 Concerns Regarding the Safety of Reprocessed Instruments

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 High-Level Disinfectants and Test Strips

      2. 5.1.2 Detergents and Wipes

      3. 5.1.3 Automated Endoscope Reprocessors

      4. 5.1.4 Endoscope Drying, Storage, and Transport Systems

      5. 5.1.5 Other Products

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Ambulatory Surgery Centers

      3. 5.2.3 Other End Users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States (By Product and By End User)

        2. 5.3.1.2 Canada (By Product and By End User)

        3. 5.3.1.3 Mexico (By Product and By End User)

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany (By Product and By End User)

        2. 5.3.2.2 United Kingdom (By Product and By End User)

        3. 5.3.2.3 France (By Product and By End User)

        4. 5.3.2.4 Italy (By Product and By End User)

        5. 5.3.2.5 Spain (By Product and By End User)

        6. 5.3.2.6 Rest of Europe (By Product and By End User)

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China (By Product and By End User)

        2. 5.3.3.2 Japan (By Product and By End User)

        3. 5.3.3.3 India (By Product and By End User)

        4. 5.3.3.4 Australia (By Product and By End User)

        5. 5.3.3.5 South Korea (By Product and By End User)

        6. 5.3.3.6 Rest of Asia-Pacific (By Product and By End User)

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC (By Product and By End User)

        2. 5.3.4.2 South Africa (By Product and By End User)

        3. 5.3.4.3 Rest of Middle East and Africa (By Product and By End User)

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil (By Product and By End User)

        2. 5.3.5.2 Argentina (By Product and By End User)

        3. 5.3.5.3 Rest of South America (By Product and By End User)

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Cantel Medical

      2. 6.1.2 Custom Ultrasonics

      3. 6.1.3 Ecolab Inc

      4. 6.1.4 Endo-Technik W. Griesat

      5. 6.1.5 Getinge AB

      6. 6.1.6 Envista Holdings Corporation (Metrex Research LLC)

      7. 6.1.7 Olympus Corporation

      8. 6.1.8 Fortive Corporation (Advanced Sterilization Products)

      9. 6.1.9 STERIS plc.

      10. 6.1.10 HOYA Corporation

      11. 6.1.11 Advanced Sterilization Products

      12. 6.1.12 Wassenburg Medical B.V.

      13. 6.1.13 Steelco S.p.A.

      14. 6.1.14 BES Rehab Ltd

      15. 6.1.15 ARC Group of Companies Inc

      16. 6.1.16 Hoya Corporation

      17. 6.1.17 Shinva Medical Instrument Co. Ltd.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Endoscope Reprocessing Market market is studied from 2018 - 2026.

The Global Endoscope Reprocessing Market is growing at a CAGR of 7.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Cantel Medical, Ecolab Inc, STERIS plc., Olympus Corporation, Getinge AB are the major companies operating in Global Endoscope Reprocessing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!